Daily subcutaneous injections of 20K-hGH in obese mice significantly reduced relative fat pad and whole body lipids by inhibiting LPL activity and stimulating lipolysis.
Does 20K-hGH reduce body fat and alter lipolysis and LPL activity in obese KV-A(y) mice?
In a preclinical model, 20K-hGH reduces body fat by inhibiting lipoprotein lipase activity and stimulating lipolysis.
AIM: The aim of this study was to estimate the lipolytic activity of the human growth hormone variant, 20-kD human growth hormone (20K-hGH). METHODS: Obese KV-A(y) mice were given daily subcutaneous injections of 20K-hGH (0.25, 0.5, 1.0 mg/kg), 22K-hGH (0.25 mg/kg) or saline as a control for 2 weeks. Body composition (fat, water and protein), lipolysis and lipoprotein lipase (LPL) activity were measured 24 h after the final injection. RESULTS: Both growth hormone isoforms significantly reduced relative fat pad and whole body lipids. In addition, 20K-hGH produced an inhibition of LPL activity in adipose tissue and stimulated lipolysis in adipocytes. CONCLUSION: These data strongly suggest that inhibition of LPL activity in adipose tissue and stimulation of lipolysis in adipocytes by 20K-hGH treatment reduce adipose tissue mass, resulting in body fat reduction.
Takahashi et al. (Tue,) conducted a other in Obesity. 20-kD human growth hormone (20K-hGH) vs. 22K-hGH (0.25 mg/kg) or saline was evaluated on Body composition (fat, water and protein), lipolysis and lipoprotein lipase (LPL) activity. Daily subcutaneous injections of 20K-hGH in obese mice significantly reduced relative fat pad and whole body lipids by inhibiting LPL activity and stimulating lipolysis.